| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/31/2007 | CN1906189A 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders |
| 01/31/2007 | CN1906188A Phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as IGF-1R inhibitors |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1906179A Maleimide resin with cyanurate core |
| 01/31/2007 | CN1906178A 喹唑啉衍生物 Quinazoline derivatives |
| 01/31/2007 | CN1906176A Therapeutic agents II |
| 01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/31/2007 | CN1906173A Protein modifier production inhibitor |
| 01/31/2007 | CN1906172A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1906161A N-sulfonyldicarboximide containing tethering compounds |
| 01/31/2007 | CN1906160A Imidazole derivatives, processes for preparing them and their uses |
| 01/31/2007 | CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases |
| 01/31/2007 | CN1905883A New derivatives of 6-4{4-[1h-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1905868A DPP-IV inhibitors |
| 01/31/2007 | CN1903853A Synthesis of 8-(4,6-dimethoxy pyrimidine oxy)-2-substituted phentriazine-1-one derivative and its herbicide activity |
| 01/31/2007 | CN1903846A Ornidazole derivative used for therapy, its preparation method and use |
| 01/30/2007 | US7169934 (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 01/30/2007 | US7169801 Antiinflammatory agents; inflammatory bowel disorders; capable of complexing with a deacetylase catalytic site and/or a metal ion |
| 01/30/2007 | US7169800 For cancer therapy |
| 01/30/2007 | US7169798 Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169790 5-substituted 2-aryl-4-pyrimidinones |
| 01/30/2007 | US7169789 Quinoline derivatives and quinazoline derivatives |
| 01/30/2007 | US7169785 e.g., 2-{[4-(Cyclohexylmethyl-amino)-6-(3-fluoro-4-methoxy-phenylamino)-[1,35]triazin-2-ylamino]-methyl}-cyclopentanone; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 01/30/2007 | US7169784 Medical devices employing triazine compounds and compositions thereof |
| 01/30/2007 | US7169781 Such as 2-(2,6-dichlorophenyl)-4-(3-chlorophenyl)-5-(2-methylthiopyrimidin-4-yl)-N H-imidazole as anticarcinogenic agent |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169777 Melanocortin receptor agonists |
| 01/30/2007 | US7169775 Amino methyl imidazoles as C5a receptor modulators |
| 01/30/2007 | US7169773 Compounds |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/30/2007 | CA2297011C Sulfonamide derivatives as therapeutic or prophylactic agent for glomerulopathy |
| 01/30/2007 | CA2260060C Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 01/30/2007 | CA2207628C 3-aryl-1,2,4-triazole derivatives with herbicidal properties |
| 01/25/2007 | WO2007011820A2 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/25/2007 | WO2007011721A1 Inhibitors of mitotic kinesin |
| 01/25/2007 | WO2007011623A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007011618A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | WO2007010964A1 Indole derivative having pgd2 receptor antagonist activity |
| 01/25/2007 | WO2007010558A1 A process for the preparation of telmisartan |
| 01/25/2007 | WO2007010390A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 01/25/2007 | WO2007010144A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | WO2007010044A1 3-indolylmethylene derivatives with cytostatic action |
| 01/25/2007 | WO2007009913A1 Pyridazinone derivatives as thyroid hormone receptor agonists |
| 01/25/2007 | WO2007009906A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | WO2007009774A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2007009739A1 Compounds |
| 01/25/2007 | WO2007009723A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009722A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009721A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009720A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009716A1 Preparation of terazole derivatives |
| 01/25/2007 | WO2007009712A1 Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
| 01/25/2007 | WO2007009706A2 Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 01/25/2007 | WO2007009702A2 Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 01/25/2007 | WO2007009689A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | WO2007009688A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 01/25/2007 | WO2007009687A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 01/25/2007 | WO2007009299A1 Optically pure n',n'-di substituted -prolylhydrazines as well as the preparation and use thereof |
| 01/25/2007 | WO2006131303A3 Peptide deformylase (pdf) inhibitors 4 |
| 01/25/2007 | WO2006127576A3 N - formyl hydroxylamine compounds as pdf inhibitors |
| 01/25/2007 | WO2006125592A3 Process for the preparation of 2-alkyl-1-((2'-substituted-biphenyl-4-yl)methyl)-imidazole, dihydroimidazole or benzimidazole derivatives |
| 01/25/2007 | WO2006122408A9 Bir domain binding compounds |
| 01/25/2007 | WO2006122254A3 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | US20070021609 4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 01/25/2007 | US20070021607 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/25/2007 | US20070021487 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 01/25/2007 | US20070021483 Amidine derivatives for treating amyloidosis |
| 01/25/2007 | US20070021482 1,5,7-Trisubstituted benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 01/25/2007 | US20070021481 Anti-androgenic N-[ omega -[3-[4-cyano-3-(trifluoromethyl)-phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]alkyl]-substituted pyrrolidines; treatment of prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism or acne |
| 01/25/2007 | US20070021469 Reacting nicotine with trimethylsilylchloride and lithium in polar aprotic solvent to form 3-(1-methylpyrrolidin-2-yl)-1,4-bis-trimethylsilanyl-1,4-dihydropyridine; chemical intermediates such as to nicotinic acetylcholine receptor modulators |
| 01/25/2007 | US20070021468 reacting succinic acid derivatives with substituted hydrazines in presence of acid scavengers and solvents, to form chemical intermediates for benzoxazinones; cyclization |
| 01/25/2007 | US20070021467 Salts of omeprazole and esomeprazole II |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021463 such as 1-[1-(1-Benzyl-1H-indole-3-carbonyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one, which act as vasopressin V1a receptor antagonists, for the treatment of dysmenorrhea, hypertension, heart failure, nephritis, obsessive compulsive disorder, anxiety and depression |
| 01/25/2007 | US20070021459 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting |
| 01/25/2007 | US20070021456 Aminobenzimidazole derivatives |
| 01/25/2007 | US20070021446 2-arylbenzothiazole analogues and uses thereof |
| 01/25/2007 | US20070021437 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/25/2007 | US20070021436 4-(7-chloro-quinazolin-4-yl)-piperidine; use in the synthesis of protein tyrosine kinase inhibitors, particularly inhibitors of FLT3 and/or c-kit and/or TrkB |
| 01/25/2007 | US20070021435 Aminopyrimidines as kinase modulators |
| 01/25/2007 | US20070021420 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 01/25/2007 | US20070021419 2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 01/25/2007 | US20070021414 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists |
| 01/25/2007 | US20070021408 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/25/2007 | US20070021407 Substituted quinolines as antitumor agents |
| 01/25/2007 | US20070021405 Aryl- and heteroarylpiperidinecarboxylate-derivatives methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021398 Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |